drugset / Trial / NCT02948842

Clostridium Histolyticum Collagenase Injection for Urethral Disease

NCT02948842

Phase 2 Completed 5 enrolled University of South Florida
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the efficacy of clostridium histolyticum collagenase (XIAFLEX®) in treating urethral strictures.

Timeline

Start
2020-05-22
Primary completion
2023-03-04
Completion
2023-04-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Collagenase Clostridium Histolyticum Protein / enzyme biologic 0.58 mg Other

Indications